Skip to main content


Overweight women have examination at dietitian-nutritionist's office (symbolic image with model)

23-09-2022 | EASD 2022 | Conference coverage | News

ADA/EASD hyperglycemia management consensus update strengthens holistic care

The latest update to the ADA and EASD hyperglycemia management consensus report places a strong emphasis on holistic, person-centered care for type 2 diabetes.


07-06-2022 | ADA 2022 | Conference coverage | News

​​​​​​​ADA/KDIGO consensus: ‘Speaking the same language’ on CKD management

The ADA and KDIGO have produced a consensus statement on treating chronic kidney disease in people with diabetes.

01-10-2021 | EASD 2021 | Conference coverage | News

ADA/EASD publish consensus report on type 1 diabetes management

The newly published ADA/EASD consensus report on the management of type 1 diabetes provides a comprehensive overview of the care required to help people with the condition live a full and healthy life.

05-06-2021 | ATTD 2021 | Conference coverage | News

Forthcoming consensus statement offers guidance on DIY closed-looping

A consensus statement covering the practical, ethical, and legal aspects of the use of open-source closed-loop insulin delivery algorithms is soon to be published, the authors reported at the virtual ATTD 2021 conference.

Best practice

05-10-2018 | Hyperglycemia | EASD 2018 | News

ADA/EASD consensus report on managing hyperglycemia in type 2 diabetes published

The final version of the 2018 update to the consensus guidelines on managing hyperglycemia in people with type 2 diabetes is now published.

05-03-2018 | Glycemic control | News

ACP backs less intensive HbA1c targets for type 2 diabetes

The American College of Physicians has issued four recommendations relating to glycated hemoglobin targets in patients with type 2 diabetes.

Read the linked commentary from Jay Shubrook

22-09-2017 | Older adults | EASD 2017 | News

Optimizing outcomes: System and patient factors

An EASD session on optimizing patient outcomes included research into the effect of guideline adherence, predictors of changes in medication adherence, and overtreatment of older people with diabetes.

08-03-2017 | Guidelines | News

Consequences of delaying treatment intensification in type 2 diabetes explored

Results of a modeling study suggest that timely intensification of oral antidiabetic treatment is associated with a lower risk for complications but a higher risk for hypoglycemia compared with delayed treatment among patients with type 2 diabetes.